Nateglinide (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Nateglinide drug offered from Actavis Pharma, Inc.. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Nateglinide |
| SUBSTANCE NAME: | NATEGLINIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-05-18 |
| END MARKETING DATE: | 0000-00-00 |
Nateglinide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nateglinide from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 60(mg/1) |
| START MARKETING DATE: | 2011-05-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3354_1c803a85-66c4-410e-abb3-1585a2b0964d |
| PRODUCT NDC: | 0591-3354 |
| APPLICATION NUMBER: | ANDA077462 |
Other NATEGLINIDE Pharmaceutical Manufacturers / Labelers:
